J&J’s Consumer Woes Finally Subside As Pharma Continues Strong
This article was originally published in The Pink Sheet Daily
Executive Summary
The multinational health care company reported significant growth in 2013 that largely was driven by its pharmaceutical division, but bolstered by the resurrection of its long-plagued consumer brands.